Try our mobile app
Screener

Reviews

2025-11-06
#dividend #APO

Apollo Global Management will pay dividends in the amount of 0.51 USD per share on 2025-11-14, which is 0.4% of the current price 133.75. Together with previous payments, the annual dividend yield will be 1.5%

(2025-08-15: 0.51 USD)
(2025-05-15: 0.51 USD)
(2025-02-17: 0.4625 USD)
2025-11-06
#dividend #EVC

Entravision Communications Corporation will pay dividends in the amount of 0.05 USD per share on 2025-12-15, which is 1.8% of the current price 2.85. Together with previous payments, the annual dividend yield will be 7.0%

(2025-09-15: 0.05 USD)
(2025-06-13: 0.05 USD)
(2025-03-14: 0.05 USD)
2025-11-06
#dividend #NMFC

New Mountain Finance will pay dividends in the amount of 0.32 USD per share on 2025-12-16, which is 3.3% of the current price 9.68. Together with previous payments, the annual dividend yield will be 13.2%

(2025-09-15: 0.32 USD)
(2025-06-13: 0.32 USD)
(2025-03-14: 0.32 USD)
2025-11-05
#reports #ZETA

[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +25.7% YoY (vs +35.1% in previous quarter and historical rate +30.7%)
- EBITDA margin 2.7% increased compared to -4.5% same period last year
- Net Debt decreased by $19 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 53.8x compared to historical level (75th percentile) of 3037x
- EV/Sales multiple is 2.8x

2025-11-05
#reports #XMTR

[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193030)
(2025-11-04, Before Market Open):

- Revenue +27.5% YoY (vs +22.6% in previous quarter and historical rate +23.1%)
- EBITDA margin -3.3% increased compared to -5.6% same period last year
- EV/Sales multiple is 5.1x

At the opening of the session the share price went up +12.9% vs S&P500 -0.9%
2025-11-05
#reports #XGN

[Exagen](https://eninvs.com/all.php?name=XGN) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193029)
(2025-11-04, Before Market Open):

- Revenue +30.8% YoY (vs +13.3% in previous quarter and historical rate +12.8%)
- EBITDA margin -11.8% increased compared to -30.8% same period last year
- EV/Sales multiple is 2.9x

At the opening of the session the share price went down -6.3% vs S&P500 -0.9%
2025-11-05
#reports #WAT

[Waters](https://eninvs.com/all.php?name=WAT) (Research instrument manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193027)
(2025-11-04, Before Market Open):

- Revenue +8.1% YoY (vs +8.7% in previous quarter and historical rate +1.8%)
- EBITDA -5.4% YoY (vs +1.7% in previous quarter and historical rate +1.3%)
- EBITDA margin 30.6% decreased compared to 35.0% same period last year
- Net Debt decreased by $144 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 22.2x compared to historical level (75th percentile) of 22.5x
- EV/Sales multiple is 7.3x

At the opening of the session the share price went up +1.8% vs S&P500 -0.9%
2025-11-05
#reports #VCYT

[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +13.8% YoY (vs +14.0% in previous quarter and historical rate +20.4%)
- EBITDA +55.6% YoY (vs -100.0% in previous quarter)
- EBITDA margin 21.2% increased compared to 15.5% same period last year
- Net Debt decreased by $56 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 61.1x compared to historical level (75th percentile) of 73x
- EV/Sales multiple is 5.1x

2025-11-05
#reports #UBER

[Uber Technologies](https://eninvs.com/all.php?name=UBER) (Ride hailing services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193024)
(2025-11-04, Before Market Open):

- Revenue +20.4% YoY (vs +18.2% in previous quarter and historical rate +20.2%)
- EBITDA +4.9% YoY (vs +66.9% in previous quarter and historical rate +79.8%)
- EBITDA margin 9.7% decreased compared to 11.1% same period last year
- Net Debt decreased by $729 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$6.4 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 36.2x compared to historical level (75th percentile) of 71.6x
- EV/Sales multiple is 3.9x

At the opening of the session the share price went down -7.8% vs S&P500 -0.9%
2025-11-05
#reports #TOST

[Toast, Inc.](https://eninvs.com/all.php?name=TOST) (Software — Infrastructure) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +25.1% YoY (vs +24.8% in previous quarter and historical rate +34.0%)
- EBITDA +82.1% YoY (vs +236.1% in previous quarter and historical rate +73.5%)
- EBITDA margin 7.5% increased compared to 5.1% same period last year
- Net Debt decreased by $156 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.6 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 43.7x compared to historical level (75th percentile) of 364.5x
- EV/Sales multiple is 2.9x

2025-11-05
#reports #TAP

[Molson Coors Beverage](https://eninvs.com/all.php?name=TAP) (Beer maker) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193021)
(2025-11-04, Before Market Open):

- Revenue -3.3% YoY (vs -2.6% in previous quarter and historical rate +4.5%)
- EBITDA -616.9% YoY (vs -1.7% in previous quarter and historical rate +14.1%)
- EBITDA margin -93.0% decreased compared to 17.4% same period last year
- Net Debt decreased by $376 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0.6 bln (negative), 6.6% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went neutrally vs S&P500 -0.9%
2025-11-05
#reports #SUPN

[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +9.1% YoY (vs -1.8% in previous quarter and historical rate +9.0%)
- EBITDA -153% YoY (vs -40.0% in previous quarter and historical rate +25.2%)
- EBITDA margin -18.2% decreased compared to 37.5% same period last year
- Net Debt increased by $248 mln over the past reporting period (7.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 49.9x compared to historical level (75th percentile) of 18.8x
- EV/Sales multiple is 3.6x

2025-11-05
#reports #STIM

[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193019)
(2025-11-04, Before Market Open):

- Revenue +94.7% YoY (vs +137.5% in previous quarter and historical rate +33.5%)
- EBITDA margin -16.2% increased compared to -36.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 25.8% of market cap
- EV/Sales multiple is 2x

At the opening of the session the share price went down -14.1% vs S&P500 -0.9%
2025-11-05
#reports #SMCI

[Super Micro Computer](https://eninvs.com/all.php?name=SMCI) (Computer Hardware) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue -15.5% YoY (vs +8.5% in previous quarter and historical rate +65.9%)
- EBITDA -63.7% YoY (vs -28.0% in previous quarter and historical rate +47.9%)
- EBITDA margin 3.7% decreased compared to 8.6% same period last year
- Net Debt increased by $991 mln over the past reporting period (35.6% of market cap)
- FCF (LTM) +$0.4 bln (positive), 13.2% of market cap
- EV/EBITDA multiple is 3.4x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 0.2x

2025-11-05
#reports #SHLS

[Shoals Technologies Group, Inc.](https://eninvs.com/all.php?name=SHLS) (Solar) reported for 2025 q3
(2025-11-04, Before Market Open):

- Revenue +33.3% YoY (vs +12.1% in previous quarter and historical rate +21.8%)
- EBITDA +175% YoY (vs -13.6% in previous quarter and historical rate +47.0%)
- EBITDA margin 16.2% increased compared to 7.8% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.4% of market cap
- EV/EBITDA multiple is 24.1x compared to historical level (75th percentile) of 34.3x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went down -10.8% vs S&P500 -0.9%
2025-11-05
#reports #SEE

[Sealed Air](https://eninvs.com/all.php?name=SEE) (Packaging manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193013)
(2025-11-04, Before Market Open):

- Revenue +0.4% YoY (vs -0.7% in previous quarter and historical rate -2.6%)
- EBITDA -0.8% YoY (vs -3.5% in previous quarter and historical rate -6.4%)
- EBITDA margin 17.6% decreased compared to 17.8% same period last year
- Net Debt decreased by $102 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 1.7x

At the opening of the session the share price went up +6.5% vs S&P500 -0.9%
2025-11-05
#reports #RYTM

[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193012)
(2025-11-04, Before Market Open):

- Revenue +54.5% YoY (vs +69.0% in previous quarter and historical rate +120.3%)
- EBITDA margin -103.9% increased compared to -133.3% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/Sales multiple is 38.5x

At the opening of the session the share price went down -9.9% vs S&P500 -0.9%
2025-11-05
#reports #RVLV

[Revolve Group](https://eninvs.com/all.php?name=RVLV) (E-commerce fashion company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193011)
(2025-11-04, After Market Close):

- Revenue +4.6% YoY (vs +9.6% in previous quarter and historical rate +3.7%)
- EBITDA +43.8% YoY (vs +11.1% in previous quarter and historical rate +21.5%)
- EBITDA margin 7.8% increased compared to 5.7% same period last year
- Net Debt decreased by $7 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 15.9x compared to historical level (75th percentile) of 40.7x
- EV/Sales multiple is 1x

2025-11-05
#reports #PSNL

[Personalis](https://eninvs.com/all.php?name=PSNL) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193004)
(2025-11-04, After Market Close):

- Revenue -46.2% YoY (vs -26.1% in previous quarter and historical rate +3.5%)
- EBITDA margin -164.3% decreased compared to -53.8% same period last year
- Net Debt increased by $22 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0 bln (positive), 5.4% of market cap
- EV/Sales multiple is 9.5x

2025-11-05
#reports #PRDO

[Perdoceo Education](https://eninvs.com/all.php?name=PRDO) (Education and Training Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193003)
(2025-11-04, After Market Close):

- Revenue +24.7% YoY (vs +25.7% in previous quarter and historical rate +7.1%)
- EBITDA +34.8% YoY (vs +6.3% in previous quarter and historical rate +18.1%)
- EBITDA margin 29.2% increased compared to 27.1% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.7% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 6.3x
- EV/Sales multiple is 1.7x

2025-11-05
#reports #PRCT

[PROCEPT BioRobotics Corporation](https://eninvs.com/all.php?name=PRCT) (Medical Devices) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +43.1% YoY (vs +49.1% in previous quarter and historical rate +68.5%)
- EBITDA margin -27.7% increased compared to -37.9% same period last year
- Net Debt increased by $8 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/Sales multiple is 4.5x